drugset / Trial / NCT00841542

Amlodipine 10 mg Tablets Under Fasting Conditions

NCT00841542

Phase 1 Completed 28 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of amlodipine from a test formulation of Amlodipine Besylate Tablets, 10 mg versus the reference Norvasc® 10 mg Tablets under fasting conditions.

Timeline

Start
2003-04
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg

Indications

No indication recorded.